نتائج البحث 371-380 من 3613 لعملية البحث عن GLP-1 therapy
... therapy as measured by objective response rate (ORR) at one month. A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In ...
... 1-2 prior lines of therapy. The primary objectives are to determine the maximum tolerated dose (MTD) or highest protocol-defined dose (HPDD); in the absence ...
A Study to Evaluate Maximizing Anti-PD-1 Therapy By Monitoring T Cell Responses In Melanoma, Lung and Other Cancer Types ... 1 monoclonal antibody, and compare ...
... (1) Cohort 1 focuses on cancers displaying a high (80-90%) frequency of MUC1 ... therapy; (2) if patient is already engaged in an ongoing cyclical systemic therapy ...
... therapy (single or multiple) and stem cell transplant. ... A Study of Immune Cell Abnormalities Found in Individual Patients who have Type 1 Diabetes and are ...
This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and ...
In the study, 122 patients will be randomized in a 1:1 ratio to receive doxorubicin treatment (Arm 1) or L19TNF treatment in combination with doxorubicin (Arm 2) ...
... treatment) in Breast Cancer 1/2 genes (BRCA 1/2) and PALB2 associated HER2-negative metastatic breast cancer. The names of the study drugs involved in this ...
... therapy without inotuzumab ozogamicin. Inotuzumab ... treatment, in order to classify patients into post-consolidation treatment groups. ... 1/2 genes (BRCA 1/2) ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.